ADIPOQ and metabolic syndrome: A study by Kondo and team demonstrated that plasma adiponectin concentrations of subjects carrying a certain variant of the AdipoQ gene (I164T mutation) were lower than those of subjects without the mutation, and that these subjects showed some features of atherosclerosis among other features of metabolic syndrome [69].